Literature DB >> 22271465

Microglia are required for astroglial Toll-like receptor 4 response and for optimal TLR2 and TLR3 response.

Thomas H Holm1, Dina Draeby, Trevor Owens.   

Abstract

Within the central nervous system, astrocytes and microglia are the primary responders to endogenous ligands released upon injury and stress, as well as to infectious pathogens. Toll-like receptors (TLRs) are implicated in recognition of both types of stimulus. Whether astrocytes respond as strongly as microglia to TLR agonists remains contentious. In this study, we have rigorously purified astrocytes to determine their capacity for autonomous TLR response, in absence of microglia. We used flow cytometry and differential adhesion as well as a myeloid lineage-specific suicide gene to purify astrocytes from mixed glial cultures and measured their response to TLR agonists. Our results show that the response of astrocytes to TLR2 and TLR3 agonists is greatly enhanced by, and response to TLR4 agonists is completely dependent on, the presence of functional microglia. In the case of the TLR4 response to lipopolysaccharide, microglia exert their effect on astrocytes at least partially through release of soluble mediators that directly activate or facilitate astrocyte responses. Our findings underline the contribution of glial crosstalk in CNS responses to injury or inflammation.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271465     DOI: 10.1002/glia.22296

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  54 in total

1.  LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14.

Authors:  Leonid Tarassishin; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2014-03-21       Impact factor: 7.452

Review 2.  Ventricular shunt infections: immunopathogenesis and clinical management.

Authors:  Yenis Gutierrez-Murgas; Jessica N Snowden
Journal:  J Neuroimmunol       Date:  2014-08-13       Impact factor: 3.478

Review 3.  Neuroimmune signaling: a key component of alcohol abuse.

Authors:  Jody Mayfield; Laura Ferguson; R Adron Harris
Journal:  Curr Opin Neurobiol       Date:  2013-02-22       Impact factor: 6.627

4.  Potent and multiple regulatory actions of microglial glucocorticoid receptors during CNS inflammation.

Authors:  M Á Carrillo-de Sauvage; L Maatouk; I Arnoux; M Pasco; A Sanz Diez; M Delahaye; M T Herrero; T A Newman; C F Calvo; E Audinat; F Tronche; S Vyas
Journal:  Cell Death Differ       Date:  2013-09-06       Impact factor: 15.828

5.  Elimination of microglia in mouse spinal cord alters the retrograde CNS plasticity observed following peripheral axon injury.

Authors:  Jessika M Hutchinson; Lori G Isaacson
Journal:  Brain Res       Date:  2019-07-08       Impact factor: 3.252

Review 6.  A Slice of the Suicidal Brain: What Have Postmortem Molecular Studies Taught Us?

Authors:  Daniel Almeida; Gustavo Turecki
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

Review 7.  The contribution of astrocytes and microglia to traumatic brain injury.

Authors:  Ila P Karve; Juliet M Taylor; Peter J Crack
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

Review 8.  Astrocytes: Heterogeneous and Dynamic Phenotypes in Neurodegeneration and Innate Immunity.

Authors:  Colm Cunningham; Aisling Dunne; Ana Belen Lopez-Rodriguez
Journal:  Neuroscientist       Date:  2018-11-17       Impact factor: 7.519

9.  Inflammatory mediators alter the astrocyte transcriptome and calcium signaling elicited by multiple G-protein-coupled receptors.

Authors:  Mary E Hamby; Giovanni Coppola; Yan Ao; Daniel H Geschwind; Baljit S Khakh; Michael V Sofroniew
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

10.  Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain.

Authors:  Sandra Jansen; Rainer Podschun; Stephen L Leib; Joachim Grötzinger; Stefanie Oestern; Matthias Michalek; Thomas Pufe; Lars-Ove Brandenburg
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.